Lycopodium Balance Sheet Health

Financial Health criteria checks 6/6

Lycopodium has a total shareholder equity of A$127.4M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$217.0M and A$89.6M respectively. Lycopodium's EBIT is A$56.1M making its interest coverage ratio -21. It has cash and short-term investments of A$67.6M.

Key information

0%

Debt to equity ratio

AU$0

Debt

Interest coverage ratio-21x
CashAU$67.56m
EquityAU$127.44m
Total liabilitiesAU$89.60m
Total assetsAU$217.04m

Recent financial health updates

No updates

Recent updates

Investors Aren't Entirely Convinced By Lycopodium Limited's (ASX:LYL) Earnings

Aug 22
Investors Aren't Entirely Convinced By Lycopodium Limited's (ASX:LYL) Earnings

Lycopodium (ASX:LYL) Is Due To Pay A Dividend Of A$0.37

Feb 23
Lycopodium (ASX:LYL) Is Due To Pay A Dividend Of A$0.37

We Discuss Why The CEO Of Lycopodium Limited (ASX:LYL) Is Due For A Pay Rise

Nov 07
We Discuss Why The CEO Of Lycopodium Limited (ASX:LYL) Is Due For A Pay Rise

Lycopodium's (ASX:LYL) Upcoming Dividend Will Be Larger Than Last Year's

Aug 26
Lycopodium's (ASX:LYL) Upcoming Dividend Will Be Larger Than Last Year's

Lycopodium (ASX:LYL) Is Increasing Its Dividend To AU$0.18

Feb 25
Lycopodium (ASX:LYL) Is Increasing Its Dividend To AU$0.18

Upgrade: Analysts Just Made A Captivating Increase To Their Lycopodium Limited (ASX:LYL) Forecasts

Nov 24
Upgrade: Analysts Just Made A Captivating Increase To Their Lycopodium Limited (ASX:LYL) Forecasts

Lycopodium (ASX:LYL) Has Announced That It Will Be Increasing Its Dividend To AU$0.15

Sep 10
Lycopodium (ASX:LYL) Has Announced That It Will Be Increasing Its Dividend To AU$0.15

Lycopodium's (ASX:LYL) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 27
Lycopodium's (ASX:LYL) Shareholders Will Receive A Bigger Dividend Than Last Year

A Look At The Intrinsic Value Of Lycopodium Limited (ASX:LYL)

Jun 07
A Look At The Intrinsic Value Of Lycopodium Limited (ASX:LYL)

Should You Buy Lycopodium Limited (ASX:LYL) For Its Dividend?

Mar 25
Should You Buy Lycopodium Limited (ASX:LYL) For Its Dividend?

Here’s What’s Happening With Returns At Lycopodium (ASX:LYL)

Mar 10
Here’s What’s Happening With Returns At Lycopodium (ASX:LYL)

Is Lycopodium Limited's (ASX:LYL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Feb 22
Is Lycopodium Limited's (ASX:LYL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

What Is The Ownership Structure Like For Lycopodium Limited (ASX:LYL)?

Feb 09
What Is The Ownership Structure Like For Lycopodium Limited (ASX:LYL)?

What Did Lycopodium's (ASX:LYL) CEO Take Home Last Year?

Jan 13
What Did Lycopodium's (ASX:LYL) CEO Take Home Last Year?

Did You Participate In Any Of Lycopodium's (ASX:LYL) Incredible 401% Return?

Dec 31
Did You Participate In Any Of Lycopodium's (ASX:LYL) Incredible 401% Return?

Three Things You Should Check Before Buying Lycopodium Limited (ASX:LYL) For Its Dividend

Dec 13
Three Things You Should Check Before Buying Lycopodium Limited (ASX:LYL) For Its Dividend

What Do The Returns At Lycopodium (ASX:LYL) Mean Going Forward?

Nov 30
What Do The Returns At Lycopodium (ASX:LYL) Mean Going Forward?

Will Weakness in Lycopodium Limited's (ASX:LYL) Stock Prove Temporary Given Strong Fundamentals?

Nov 17
Will Weakness in Lycopodium Limited's (ASX:LYL) Stock Prove Temporary Given Strong Fundamentals?

Is Lycopodium Limited's(ASX:LYL) Recent Stock Performance Tethered To Its Strong Fundamentals?

Jul 27
Is Lycopodium Limited's(ASX:LYL) Recent Stock Performance Tethered To Its Strong Fundamentals?

Financial Position Analysis

Short Term Liabilities: LYL's short term assets (A$180.4M) exceed its short term liabilities (A$77.1M).

Long Term Liabilities: LYL's short term assets (A$180.4M) exceed its long term liabilities (A$12.5M).


Debt to Equity History and Analysis

Debt Level: LYL is debt free.

Reducing Debt: LYL had no debt 5 years ago.

Debt Coverage: LYL has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: LYL has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 07:29
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lycopodium Limited is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven AnastasiouBell Potter
David EvansBofA Global Research
Raju AhmedCCZ Equities Pty Limited